Investment Summary

General Atlantic Invests In Conexa

On June 25, 2020, growth capital firm General Atlantic invested in healthcare services company Conexa

Investment Highlights
  • This is General Atlantic’s 16th transaction in the Healthcare Services sector.
  • This is General Atlantic’s 12th transaction in Brazil.

Investment Summary

Date 2020-06-25
Target Conexa
Sector Healthcare Services
Investor(s) General Atlantic
Deal Type Venture

Target

Conexa

Rio de Janeiro, Brazil
Conexa is a telemedicine provider in Brazil with the mission of revolutionizing access to healthcare and making the patient experience more humane, easier and safer. Conexa was founded in 2017 and is based in Rio de Janeiro, Brazil.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

General Atlantic

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1980
PE ASSETS 105.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

General Atlantic is a large private equity firm that invests globally in growth-oriented public and private companies. Broad areas of interest include financial services, media and consumer, healthcare, enterprise solutions, communications and electronics, and energy. General Atlantic looks to invest $40 to $400 million in transactions that support growth, expansions, buy-outs, consolidations and build-ups. General Atlantic seeks to make 8 to 12 investments per year with an investment horizon of five to ten years. The Firm's geographic coverage spans North America; Europe; Asia/Pacific; and India. General Atlantic was formed in 1980 and is based in New York, New York.


DEAL STATS #
Overall 252 of 364
Sector: Healthcare Services M&A 16 of 25
Type: Venture M&A Deals 55 of 98
Country: Brazil M&A 12 of 19
Year: 2020 M&A 16 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-25 HUTCHMED

Hong Kong, China

HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. HUTCHMED was founded in 2000 and is based in Hong Kong, China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-07 Avant

Chicago, Illinois, United States

Avant is a provider of insurance solutions to Transportation, Supermarket, and Cannabis industries. Avant was founded in 1973 and is based in Chicago, Illinois.

Sell -